Advanced Materials and Chemicals (AMC) Growth
The AMC business showed continued revenue growth, demonstrating successful investments in this area.
U.S. Manufacturing Commitment
Kodak reinforced its commitment to U.S. manufacturing, with several products like motion picture film, digital printers, ink, and chemicals made domestically.
Pharmaceutical Manufacturing Initiative
Kodak's cGMP pharmaceutical manufacturing facility is now FDA registered and certified to manufacture and sell regulated pharmaceutical products.
Series C Preferred Stock Exchange
The Series C preferred stock was exchanged for common stock, eliminating $100 million in preferred stock and over $24 million in accrued dividends.
Pension Plan Termination Process
The KRIP termination is proceeding as planned, with an estimated $500 million to revert to the company, aiding in debt reduction.